Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

NCT01315236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycobacterium Infections, Nontuberculous

Interventions

DRUG: Liposomal amikacin for inhalation (LAI)
DRUG: placebo

Sponsor

Insmed Incorporated

Collaborators

[object Object]